STRO-002
TSL-B2276-1-01
Phase 2 mab completed
Quick answer
STRO-002 for Neoplasm Malignant is a Phase 2 program (mab) at SUTRO BIOPHARMA, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SUTRO BIOPHARMA, INC.
- Indication
- Neoplasm Malignant
- Phase
- Phase 2
- Modality
- mab
- Status
- completed